Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ProCure Proton Centers Select RayStation® for Proton Planning

Published: Thursday, December 26, 2013
Last Updated: Thursday, December 26, 2013
Bookmark and Share
CE marking and clearance in the US for PBS is expected in early 2014.

RaySearch Laboratories AB has received two orders for its RayStation® treatment planning system from the proton treatment centers Seattle ProCure Management LLC in Seattle, Washington, and Princeton ProCure Management LLC in Princeton, New Jersey.

Tony Wong, Director of Physics at the Seattle ProCure Treatment Center and Dennis Mah, Director of Physics at the New Jersey ProCure Treatment Center, comment: “There are several reasons why we selected RayStation®. The most important benefits are the breadth of technology, high speed of planning and dose computation and ease of analysis compared to other modalities. This is the best system currently available in terms of robust optimization, computational accuracy and ease of use.”

Marc Mlyn, President of RaySearch Americas, adds: “ProCure is a well-known name in proton therapy, and given the strong partnerships between RaySearch, IBA and now Procure, we are confident that this is a big step forward for all of us and how proton planning can evolve. We are looking forward to a long and mutually beneficial partnership with ProCure Management.”

“ProCure is an organization focused on quality of care and efficient technologies. We see RaySearch as a good partner for us now and into the future, and we plan on working with them to achieve our corporate vision for improving the lives of patients with cancer by increasing access to proton therapy”, says Howard Rubin, Senior Vice President of Information Systems at ProCure.

“These orders further cement our position as the leading supplier of treatment planning software for particle therapy. Together with our customers and our partner IBA, we will continue to refine our tools for proton and carbon ion therapy to fully utilize the unique technical properties of these treatment techniques to enable cancer treatments of the highest precision”, says Johan Löf, CEO of RaySearch Laboratories.

The current version of RayStation® that has FDA clearance supports the proton treatment techniques Uniform Scanning and Double Scattering.

Support for PBS / IMPT has been released in Europe with CE marking and 510(k) clearance in the US for PBS is expected in early 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UMCG Selects RayStation
RayStation will replace the hospital’s existing system for conventional (photon) radiation therapy and will be the treatment planning system for its new proton therapy center.
Friday, September 23, 2016
Queen Elizabeth Hospital Birmingham Selects Raystation
The agreement includes both clinical and research licenses, and the installation will include adaptive planning, multi-criteria optimization, automated breast planning, scripting and radiobiology.
Saturday, September 17, 2016
IBA, RaySearch Collaborate
Collaboration aims to offer a unique integrated comprehensive solution for adaptive proton radiation therapy.
Tuesday, September 06, 2016
RayStation Chosen For Several New Proton Therapy Centers in Japan
The centers will deliver radiation treatments using Mitsubishi Electric's proton therapy system.
Thursday, July 28, 2016
South Florida’s First Proton Therapy Center Selects RayStation
The proton therapy facility will serve a wider region, giving patients in Latin America and the Caribbean access to the benefits of proton therapy.
Friday, July 22, 2016
Distribution Agreement in Saudi Arabia and Jordan
TMSJ assumes full responsibility for the marketing, sales and service of RayStation.
Friday, July 10, 2015
UMCG and RaySearch Initiate Collaboration Within Adaptive Radiation Therapy
RaySearch receives an order for RayStation® treatment planning system from UMCG.
Monday, October 14, 2013
RaySearch and IBA to Increase Proton Therapy Precision
Collaboration agreement signed on the development of proton treatment planning system.
Thursday, May 23, 2013
Scientific News
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Examining mtDNA May Help Identify Unknown Ancestry That Influences Breast Cancer Risk
Researchers studying mtDNA in a group of triple negative breast cancer patients found that 13 percent of participants were unaware of ancestry that could influence their risk of cancer.
Bacteria Use Ranking Strategy to Fight Off Viruses
Researchers have explained why microbes store virus confrontation information sequentially, with most recent attacks first.
Gene Therapy Technique May Help Prevent Cancer Metastasis
Gene-regulating RNA molecules could help treat early-stage breast cancer tumors before they spread.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
The Genetics of Blood Pressure
Researchers have identifed areas of the genome associated with blood-pressure including 17 previously unknown loci.
Mosquito Genetics Determine Tastes
Study reveals mosuito's preference for human versus animal biting is determined by genetics.
Quadruple Helix DNA Aids Cancer Therapies
Researchers have identified the role that a four-stranded version of DNA may play in the role of cancer progression.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!